FDA June 7, 2021 5:21 pm

FDA Approves Biogen's New Alzheimer's Drug

The FDA has approved a controversial drug for Alzheimer’s disease developed by Cambridge-based pharmaceutical company Biogen.

US & World Videos

Exit mobile version